Justin Klee
Vermogen: 51 M $ op 31-05-2026
Vermogen: 51 M $ op 31-05-2026
Justin Klee is the founder of Amylyx Pharmaceuticals, Inc., founded in 2013, and holds the title of Co-Chief Executive Officer & Executive Director since 2014.
Former job includes Member at Harvard Medical School.
Education includes undergraduate degree from Brown University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-04-2026 | 3.583.481 ( 3,22% ) | 51 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| AMYLYX PHARMACEUTICALS, INC. | Oprichter | 01-01-2013 |
| Bedrijven | Functie | Einde |
|---|---|---|
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products to cure neurodegenerative diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau